MODACARE MD 200

What is MODACARE MD 200?

MODACARE MD 200 is a medication belonging to the group of agents for maintaining wakefulness and correcting excessive daytime sleepiness. The main active ingredient of the drug is modafinil, which exerts an activating effect on the central nervous system, yet does not belong to classic amphetamine-type psychostimulants. The manufacturer of MODACARE MD 200 is the pharmaceutical company Careclub, which specializes in the production of high-quality generics and products in categories. The drug is available in tablet form at a dose of 200 mg, which provides a pronounced and long-lasting therapeutic effect throughout the day. The pharmacological action of MODACARE MD 200 is directed at increasing alertness, improving cognitive functions, and reducing feelings of fatigue in patients with sleep-wake cycle disorders.

MODACARE MD 200 is used in medical practice for treating pathological sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work sleep disorder. The mechanism of action of modafinil differs from traditional stimulants, as it selectively affects specific brain regions responsible for regulating the sleep-wake cycle. Thanks to this approach, the medication has a lower potential for dependency development and less pronounced side effects compared to other agents in this group. It is important to understand that MODACARE MD 200 does not replace full sleep, but only helps maintain the necessary level of activity in cases where sleepiness is pathological. Administration of the drug should occur exclusively as prescribed by a physician after a thorough examination and establishing an accurate diagnosis.

The medication MODACARE MD 200 from Careclub stands out for its stable production quality and compliance with international pharmaceutical industry standards. In the product category of ASSURANS, CENFORCE, MALEGRA, this agent is positioned as a reliable tool for correcting conditions associated with impaired alertness and concentration. Clinical studies confirm the efficacy of modafinil in reducing episodes of uncontrolled falling asleep and improving the quality of life of patients. MODACARE MD 200 can also be used as part of combination therapy for certain neurological disorders, although such a prescription requires an individualized approach. Before starting the intake, it is mandatory to consult a specialist, as self-medication can lead to undesirable health consequences.

What is MODACARE MD 200 prescribed for?

The main indications for the use of MODACARE MD 200 are conditions accompanied by excessive daytime sleepiness, which significantly impairs the professional activity and social life of the patient. Most often, the drug is prescribed for narcolepsy — a chronic neurological disorder characterized by sudden sleep attacks and cataplexy. In such cases, MODACARE MD 200 helps maintain a state of wakefulness during the active part of the day and reduces the frequency of uncontrolled sleep episodes. The drug is also effective for obstructive sleep apnea, when nighttime breathing is disturbed, leading to chronic sleep deprivation and severe daytime sleepiness. In this situation, MODACARE MD 200 is used as an adjunct to primary therapy aimed at eliminating the cause of apnea.

Another important indication for prescribing MODACARE MD 200 is shift work sleep disorder, which occurs in people working night shifts or on an irregular schedule. Such a regimen disrupts the body's natural biological rhythms, leading to chronic fatigue, reduced concentration, and an increased risk of errors in the workplace. MODACARE MD 200 helps adapt to an unconventional schedule by maintaining the required level of alertness during periods when the body is physiologically inclined to sleep. The medication may also be used in certain forms of depression accompanied by pronounced asthenia and sleepiness, although such a prescription requires special caution. In all cases, the decision on the appropriateness of using MODACARE MD 200 is made by a doctor based on the full clinical picture.

MODACARE MD 200 also finds application in patients with cognitive impairments associated with chronic fatigue or intense mental strain. The medication improves the ability to concentrate, increases the speed of information processing, and contributes to preserving working capacity over long periods. It is worth noting that MODACARE MD 200 is not intended for treating ordinary fatigue in healthy individuals who simply lack sleep due to an improper daily routine. Using the drug without medical indications can be dangerous and lead to the development of side effects. The body's individual response to modafinil may vary, so it is important to follow doctor recommendations and not exceed the prescribed dose.

Composition and active components of MODACARE MD 200

The main active substance of MODACARE MD 200 is modafinil at a dosage of 200 mg per single tablet. Modafinil is a synthetic compound belonging to the group of wakefulness-promoting agents, and structurally it differs from amphetamines and other classic psychostimulants. The mechanism of action of modafinil involves increasing dopamine concentration in the synaptic cleft by blocking its reuptake, which leads to the activation of specific brain areas. In addition, modafinil affects the histamine and orexin systems, which play a key role in regulating the sleep-wake cycle. Such a multi-component mechanism provides a pronounced therapeutic effect without significant excitation of the peripheral nervous system.

Auxiliary components of MODACARE MD 200 include lactose, microcrystalline cellulose, starch, magnesium stearate, and other substances that ensure the stability of the tablet and its proper absorption in the gastrointestinal tract. These components do not possess independent pharmacological activity, but they play an important role in ensuring the bioavailability of modafinil. The drug MODACARE MD 200 from the manufacturer Careclub undergoes strict quality control at all stages of production, guaranteeing that the active substance content matches the declared dosage. The tablet manufacturing technology ensures an even release of modafinil, allowing for a stable concentration of the drug in the blood throughout the day. This is especially important for patients who require prolonged maintenance of wakefulness without sharp fluctuations in effect.

The pharmacokinetics of MODACARE MD 200 are characterized by rapid absorption after oral administration, with peak plasma concentration reached in approximately 2–3 hours. The elimination half-life of modafinil is about 12–15 hours, which allows taking the medication once daily, usually in the morning. Modafinil metabolism occurs primarily in the liver with the participation of cytochrome P450 system enzymes, which should be taken into account when used concurrently with other medications. Excretion of metabolites occurs mainly via the kidneys, so patients with impaired renal function may require a dose adjustment. Understanding the pharmacokinetic features of MODACARE MD 200 helps the physician correctly select the dosing regimen for each individual patient.

Dosage of MODACARE MD 200

The standard recommended dose of MODACARE MD 200 for adult patients is 200 mg once daily, usually taken in the morning. This dosing regimen ensures the maintenance of wakefulness throughout the active period of the day without disrupting night sleep. For patients with narcolepsy and obstructive sleep apnea, this dose is optimal in most cases; however, depending on individual response, a physician may adjust it. In some situations, a reduction of the dose to 100 mg per day is possible, especially for elderly patients or individuals with hypersensitivity to modafinil. The maximum daily dose should not exceed 400 mg, as a further increase does not lead to an enhanced therapeutic effect but increases the risk of side effects.

The duration of the treatment course with MODACARE MD 200 is determined individually by the doctor depending on the nature of the disease and the patient's response to therapy. In narcolepsy and obstructive sleep apnea, the drug can be prescribed for a long period, sometimes for several months or years, with regular monitoring of the patient's condition. For shift work sleep disorder, MODACARE MD 200 is usually taken only on days when it is necessary to work a night shift or maintain wakefulness at an unusual time. It is important not to discontinue the medication abruptly, especially after long-term use, as this can lead to the return of sleepiness symptoms. A doctor may recommend a gradual dose reduction to minimize potential withdrawal reactions.

For patients with impaired liver function, the dose of MODACARE MD 200 is usually reduced by half, since the metabolism of the drug takes place in this organ. Patients with severe renal impairment also require careful use and potential dose adjustment under medical supervision. For elderly individuals, it is recommended to start therapy with the minimum effective dose, as side effects are observed more frequently in this patient group. MODACARE MD 200 is not intended for use in children and adolescents under 18 years of age due to the lack of sufficient safety data. Any dose change must be carried out only in agreement with the doctor, who takes into account all individual characteristics of the patient.

How to take MODACARE MD 200 correctly?

MODACARE MD 200 should be taken in the morning, preferably at the same time, to ensure a stable level of the drug in the body and avoid disruption of nighttime sleep. The tablet is swallowed whole with a sufficient amount of water, without chewing or crushing, as this may affect the rate of absorption of the active substance. Taking the drug does not depend on food intake; however, in some patients, taking it with food may slightly delay the onset of the effect. For patients working night shifts, MODACARE MD 200 is recommended to be taken approximately one hour before starting work to ensure maximum alertness during the required period. It is important not to take the drug late in the afternoon or evening, as this can cause insomnia and disrupt the natural sleep cycle.

If a patient missed a dose of MODACARE MD 200, the drug should be taken as soon as possible; however, if there are less than 8 hours left before the next planned dose, it is better to skip the missed dose. It is not recommended to double the dose to compensate for the missed one, as this increases the risk of side effects. During therapy with MODACARE MD 200, it is important to maintain a regular sleep and rest schedule, as the drug does not replace the body's physiological need for recovery. Patients should avoid consuming large amounts of caffeinated beverages during treatment, as this can enhance the stimulatory effect and cause anxiety or tachycardia. It is also necessary to refrain from driving vehicles and operating machinery until individual response to the drug is established.

While taking MODACARE MD 200, it is recommended to keep a well-being diary, recording alertness levels, night sleep quality, and possible side effects. This will help the doctor evaluate the efficacy of the therapy and adjust the dosage if necessary. Patients with cardiovascular diseases should regularly monitor blood pressure and heart rate, as modafinil can affect these parameters. MODACARE MD 200 should not be taken together with alcohol, as this can lead to unpredictable reactions and increased toxic load on the liver. If any unusual symptoms appear, it is necessary to contact a physician to determine further treatment tactics.

Side effects of MODACARE MD 200

The most common side effects of MODACARE MD 200 are headache, nausea, dry mouth, and decreased appetite. These symptoms usually occur at the beginning of therapy and are temporary in nature, gradually diminishing as the body adapts to the drug. Some patients may experience increased anxiety, nervousness, or sleep disturbances, especially if the drug is taken later than the recommended time. Dizziness, palpitations, and a slight increase in blood pressure are also possible, requiring monitoring in patients with cardiovascular pathology. It is important to understand that the body's individual reaction to MODACARE MD 200 may vary, so the appearance of any undesirable symptoms should be discussed with a doctor.

Less frequent side effects of MODACARE MD 200 include skin rashes, itching, urticaria, and other allergic reactions that may indicate hypersensitivity to the components of the preparation. In rare cases, severe skin reactions may develop, such as Stevens-Johnson syndrome or toxic epidermal necrolysis, which require immediate discontinuation of the drug and medical attention. On the psychiatric side, depressive states, hallucinations, manic episodes, or suicidal thoughts may occur, especially in patients with pre-existing psychiatric disorders in their history. Such manifestations demand urgent consultation with a specialist and a review of the therapeutic strategy. MODACARE MD 200 can also cause gastrointestinal disturbances, including diarrhea, constipation, or abdominal pain.

Patients should consult a doctor immediately if chest pain, heart rhythm disturbances, severe shortness of breath, or limb swelling occur while taking MODACARE MD 200. These symptoms may indicate serious cardiovascular complications requiring urgent medical intervention. The appearance of seizures, loss of consciousness, or severe psychiatric disorders is also a reason for urgent medical attention. Prolonged use of MODACARE MD 200 can lead to the development of tolerance, where the efficacy of the drug decreases, requiring a dosage review or replacement of therapy. The physician should regularly evaluate the benefit-risk ratio of continuing treatment for each specific patient.

Contraindications of MODACARE MD 200

MODACARE MD 200 has a number of absolute contraindications, in the presence of which taking the medication is strictly prohibited. These include hypersensitivity to modafinil or any auxiliary component of the drug, which may manifest as allergic reactions of varying severity. The drug is not prescribed to patients with severe cardiovascular diseases, including uncontrolled arterial hypertension, arrhythmias, ischemic heart disease, and recent myocardial infarction. MODACARE MD 200 is also contraindicated in the presence of psychiatric disorders such as schizophrenia, bipolar affective disorder, or severe depression with psychotic symptoms. The drug is not prescribed to patients with prostatic hypertrophy, angle-closure glaucoma, and pheochromocytoma due to the risk of exacerbating these conditions.

Relative contraindications include conditions under which MODACARE MD 200 may be used only with extreme caution and under close medical supervision. This applies to patients with impaired liver or kidney function, as the metabolism and excretion of the drug may be slowed down. For individuals with a history of epilepsy or seizure disorders, MODACARE MD 200 is prescribed only in cases where the expected benefit outweighs the potential risk, as the drug may lower the seizure threshold. Patients with alcohol or drug addiction require special monitoring during therapy due to the potential risk of drug abuse. MODACARE MD 200 is not recommended for use during pregnancy, as safety data regarding modafinil for the fetus are limited and suggest a potential teratogenic effect.

MODACARE MD 200 is not prescribed to children and adolescents under 18 years of age, as clinical studies on safety and efficacy in this age group have not been conducted. Women of childbearing potential are recommended to use reliable methods of contraception during therapy with MODACARE MD 200, as the drug can reduce the effectiveness of hormonal contraceptives. During breastfeeding, taking the drug is contraindicated, as modafinil passes into breast milk and may affect the child. For elderly patients, MODACARE MD 200 is prescribed with caution and in minimal effective doses due to an increased risk of side effects. Before starting therapy, a full medical examination must be conducted to exclude possible contraindications.

Interaction of MODACARE MD 200 with other drugs and alcohol

MODACARE MD 200 can interact with many medications, so before starting therapy, it is necessary to inform your doctor about all drugs the patient is taking. Special attention is required for concurrent use with hormonal contraceptives, as modafinil accelerates their metabolism in the liver and significantly reduces contraceptive efficacy. Women are advised to use additional or alternative methods of contraception during therapy with MODACARE MD 200 and for one month after its completion. The drug may also decrease the efficacy of cyclosporine, certain antiviral agents, and antidepressants, requiring adjustment of their dosages. Concomitant use with MAO inhibitors, tricyclic antidepressants, and selective serotonin reuptake inhibitors requires special caution due to the risk of developing serotonin syndrome.

Consumption of alcohol during therapy with MODACARE MD 200 is strictly not recommended, as it can lead to unpredictable reactions and increased toxic load on the liver. Alcohol can both enhance and diminish the effect of modafinil, as well as increase the risk of side effects from the cardiovascular and nervous systems. MODACARE MD 200 can affect the ability to drive vehicles and operate machinery, especially at the beginning of therapy or when changing the dose. Patients should refrain from potentially hazardous activities until their individual reaction to the drug is determined. Combining MODACARE MD 200 with other stimulants, including high doses of caffeine, can lead to excessive agitation, anxiety, and heart rhythm disturbances.

Where to buy MODACARE MD 200 in Ukraine

MODACARE MD 200 from the manufacturer Careclub is available for purchase in Ukraine through a network of specialized pharmacies and online platforms selling medicines of the ASSURANS, CENFORCE, MALEGRA categories. The drug is dispensed by prescription, so before purchasing it is necessary to have an appropriate prescription from a qualified specialist. The cost of MODACARE MD 200 may vary depending on the region, pharmacy chain, and availability of promotional offers, so it is recommended to compare prices at different sales points. When purchasing, it is important to pay attention to the integrity of the packaging, the expiration date, and the presence of protective elements confirming the authenticity of Careclub products. Ordering MODACARE MD 200 online usually involves convenient delivery throughout Ukraine, which is particularly relevant for patients in remote settlements.

MODACARE MD 200 must be stored in its original packaging at a temperature not exceeding 25 degrees Celsius in a dry place, protected from light and inaccessible to children. The shelf life of the drug is usually 2–3 years from the date of manufacture, after which use is strictly prohibited. Before starting therapy with MODACARE MD 200, be sure to consult a doctor to determine the appropriateness of use, correct dosage, and rule out possible contraindications. Remember that self-medication can be dangerous to your health, and the body's individual reaction to the drug may differ from expected. Only a qualified medical professional can make an informed decision regarding the prescription of MODACARE MD 200 and ensure safe monitoring of therapy.